Business Context and Reporting Period
Company: Superior Surgical Mfg. Co., Inc. (Superior Group of Companies, Inc.)
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Quarter and nine months ended September 30, 1997
Business Overview: The registrant operates in the healthcare marketplace, manufacturing surgical products. The company reported 7,977,652 common shares outstanding as of the report date.
Key Financial Metrics
| Metric | Three Months Ended Sep 30, 1997 | Nine Months Ended Sep 30, 1997 |
|---|---|---|
| Net Sales | $37,117,239 | $108,149,043 |
| Net Earnings | $2,458,193 | $6,606,851 |
| Earnings Per Share (EPS) | $0.31 | $0.83 |
| Cash Dividends Declared | $0.11 per share | $0.33 per share |
| Operating Cash Flow (9mo) | $11,191,751 | |
| Cash and Certificates of Deposit | $9,432,898 (as of Sep 30, 1997) | |
| Total Debt | $16,450,000 ($2,266,667 current + $14,183,333 long-term) | |
| Cost of Goods Sold Margin | Approx. 66.4% of sales (9mo) | |
| Selling & Admin Expense Margin | Approx. 23% of sales (9mo) |
Material Changes vs. Prior Period
- Revenue Growth: Net sales for the nine months ended September 30, 1997, increased approximately 3% to $108.1 million compared to $105.0 million in the prior year period. While the first quarter saw a 3% decline due to market weakness, the second and third quarters saw increases of 8% and 5%, respectively.
- Profitability: Net earnings for the three months ended September 30, 1997, rose 8% to $2.46 million from $2.28 million in the prior year quarter. Nine-month net earnings increased to $6.61 million from $6.32 million.
- Expense Management: Interest expense decreased 12% to $852,647 for the nine-month period, attributed to debt repayment and higher cash balances invested in certificates of deposit.
- Balance Sheet: Accounts receivable increased 12.5% year-over-year, while inventories decreased 2.7% due to higher turnover of finished goods. Accounts payable increased 28% primarily due to increased inventory purchases.
- Debt Reduction: Total debt decreased by $1,550,000 from December 31, 1996, due to scheduled repayments.
Outlook, Risks, and Management Commentary
- Market Conditions: Management noted initial weakness in healthcare markets in Q1 1997, followed by continued momentum in economic activities in Q2 and Q3.
- Liquidity: Cash and certificates of deposit increased by $4.7 million to $9.4 million. The company has $10 million available under its existing revolving Credit Agreement. Management believes current cash flows and credit sources are adequate for foreseeable funding requirements.
- Capital Expenditures: The company plans to continue its ongoing capital expenditure program to maintain and improve facilities, evaluating spending based on prevailing economic conditions.
- Risks and Contingencies: The filing states there are no pending legal proceedings (Item 1, Part II). Management notes that financial statements involve estimates and assumptions that could differ from actual results. The filing includes a standard disclaimer that interim results are not necessarily indicative of full-year results.
Investor Verification Checklist
- Verify the sustainability of the 8% and 5% sales growth in Q2 and Q3 against the Q1 decline to assess market recovery trends.
- Confirm the impact of the 12.5% increase in accounts receivable on future cash collection cycles.
- Review the terms of the $10 million revolving Credit Agreement to understand covenants and availability.
- Monitor the 28% increase in accounts payable to ensure it reflects strategic purchasing rather than liquidity constraints.
- Validate the 66.4% cost of goods sold margin stability in the context of raw material price fluctuations.